Biote Holdings, a provider of hormone-replacement therapies, is going public through a merger with blank-check company Haymaker Acquisition Corp. III, sources say https://t.co/7YIgil0EA5
— Bloomberg Markets (@markets) December 13, 2021
Source: Twitter
Share this:
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.